CareDx CDNA Reportable Segment — Gain (Loss) from Litigation Settlement
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CareDx in its filing.
Tagged under the XBRL concept us-gaap:GainLossRelatedToLitigationSettlement.
The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about CareDx's reportable segment — gain (loss) from litigation settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CareDx's reportable segment — gain (loss) from litigation settlement?
- CareDx (CDNA) reported reportable segment — gain (loss) from litigation settlement of -$600K in Q1 2026.
- How has CareDx's reportable segment — gain (loss) from litigation settlement changed year-over-year?
- CareDx's reportable segment — gain (loss) from litigation settlement increased by 88.8% year-over-year, from -$5.36M to -$600K.
- What is the long-term trend for CareDx's reportable segment — gain (loss) from litigation settlement?
- Over 2 years (2023 to 2025), CareDx's reportable segment — gain (loss) from litigation settlement has grown at a -75.6% compound annual growth rate (CAGR), from -$96.3M to -$5.71M.
- What does reportable segment — gain (loss) from litigation settlement mean?
- Captures the financial impact of legal settlements, including both gains from favorable outcomes and losses from adverse judgments or agreements. These items are typically non-recurring and can significantly distort the segment's reported operating performance in a given period.